Evaluation of Myocardial Damage After Electroconvulsive Therapy: Analyses of High-Sensitive Cardiac Troponin I and N-Terminal pro-B-type Natriuretic Peptide.
Journal
Pharmacopsychiatry
ISSN: 1439-0795
Titre abrégé: Pharmacopsychiatry
Pays: Germany
ID NLM: 8402938
Informations de publication
Date de publication:
Feb 2019
Feb 2019
Historique:
pubmed:
3
7
2018
medline:
19
3
2019
entrez:
3
7
2018
Statut:
ppublish
Résumé
Electroconvulsive therapy (ECT) is a remarkably safe procedure. However, there might exist a subgroup of patients with an increased risk for cardiovascular events. The cardiac-specific enzymes high-sensitive cardiac troponin I (hscTnI) and N-terminal pro-B-type natriuretic peptide (NT-proBNP) were measured before and after ECT in 23 patients. No relevant increase of hscTnI after ECT was found. Mean NT-proBNP levels were higher after ECT and in three patients a new NT-proBNP elevation after ECT was identified. In conclusion, our small study did not find any evidence for myocardial damage due to ECT by measuring hsTnI, but an increase of NT-proBNP, whose clinical relevance could only be speculated, yet.
Substances chimiques
N-terminal proatrial natriuretic peptide
0
Protein Precursors
0
Troponin I
0
Atrial Natriuretic Factor
85637-73-6
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
92-93Informations de copyright
© Georg Thieme Verlag KG Stuttgart · New York.
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.